LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease

被引:9
|
作者
Patra, Biswanath [2 ]
Parsian, Azemat J. [1 ]
Racette, Brad A. [3 ]
Zhao, Jing Hua [4 ]
Perlmutter, Joel S. [3 ]
Parsian, Abbas [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Radiat Oncol, Little Rock, AR 72205 USA
[2] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
[3] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[4] Strangeways Res Lab, MRC, Epidemiol Unit, Cambridge CB1 4RN, England
基金
美国国家卫生研究院;
关键词
LRRK2; SNPs; Parkinson's disease; Haplotype; ALPHA-SYNUCLEIN; LINKAGE PHASE; ASSOCIATION; DEMENTIA; TRAITS; LOCUS; TESTS; ONSET; MAPS;
D O I
10.1016/j.parkreldis.2008.05.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutation within the leucine-rich repeat kinase 2 (LRRK2) gene has been identified as a cause of autosomal dominant Parkinson's disease (PD). The purpose of this Study was to determine the frequency of G2019S Mutation and whether the differences in the allele and genotype distribution of six SNPs within LRRK2 gene are associated with PD in an American non-Hispanic white population. The sample included 350 sporadic PD (SPD), 225 familial PD (FPD) patients and 186 controls of the same race and ethnicity. The frequency of LRRK2 G2019S mutation in our total sample of PD (FPD and SPD) was 1.56%. The frequency of this mutation was 3.5% in the FPD and 0.3% ill the SPD groups, respectively. Allele and genotype frequencies of six SNPs were compared between PD and control samples. In addition, PD groups were categorized by sporadic PD (no family history), familial PD (first degree relative with PD) and age of onset (AON, <= 50 or >= 51 years). The haplotypes of the six SNPs were also constructed for association analysis. After correction for multiple comparisons, there was no association between any SNPs (allele or genotype) and PD groups. One of the haplotypes was modestly associated with the combined PD (SPD and FPD) sample. There was also no association with age at onset of PD. Our Study suggests that the LRRK2 gene may be a risk factor or the cause for a very small fraction of PD in American white Population. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [1] Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease
    Lesage, Suzanne
    Leclere, Laurence
    Lohmann, Ebba
    Borg, Michel
    Ruberg, Merle
    Duerr, Alexandra
    Brice, Alexis
    [J]. NEURODEGENERATIVE DISEASES, 2007, 4 (2-3) : 195 - 198
  • [2] LRRK2 mRNA and protein expression in Parkinson's disease cases with LRRK2 G2019S mutation
    Sharma, S.
    Bandopadhyay, R.
    Kingsbury, A. E.
    Lashley, T. C.
    Lees, A. J.
    Revesz, T.
    Wood, N. W.
    Holton, J. L.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 27 - 28
  • [3] The LRRK2 G2019S Mutation Predisposes Parkinson's Disease Patients to Cancer
    Inzelberg, Rivka
    Cohen, Oren S.
    Aharon-Peretz, Judith
    Schlesinger, Ilana
    Yaakov, Zichron
    Gershoni-Baruch, Ruth
    Djaldetti, Ruth
    Nitzan, Zeev
    Ephraty, Lilach
    Tunkel, Olga
    Kozlova, Evgenya
    Inzelberg, Lilah
    Schechtman, Edna
    Kaplan, Natali
    Friedman, Eitan
    Hassin-Baer, Sharon
    [J]. NEUROLOGY, 2011, 76 (09) : A17 - A17
  • [4] The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews
    Thaler, Avner
    Ash, Elissa
    Gan-Or, Ziv
    Orr-Urtreger, Avi
    Giladi, Nir
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (11) : 1473 - 1482
  • [5] The LRRK2 G2019S mutation predisposes Parkinson's disease patients to cancer
    Inzelberg, R.
    Cohen, O.
    Aharon-Peretz, J.
    Schlesinger, I.
    Gershoni-Baruch, R.
    Djaldetti, R.
    Nitsan, Z.
    Ephraty, L.
    Tunkel, O.
    Kozlova, E.
    Inzelberg, L.
    Kaplan, N.
    Schechtman, E.
    Friedman, E.
    Hassin-Baer, S.
    [J]. MOVEMENT DISORDERS, 2011, 26 : S310 - S310
  • [6] The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease
    Cho, J.
    Kim, H.
    Park, S.
    Jeon, B.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S402 - S402
  • [7] LRRK2 G2019S Mutation in an Argentinean Cohort of Patients with Parkinson's Disease
    Gatto, Emilia M.
    Converso, Daniela P.
    Marti-Masso, Jose F.
    Sebastian, San
    Ruiz, Coro Paisan
    Persi, Gabriel
    Etcheverry, Jose L.
    Parisi, Virginia
    Leiguarda, Fernando
    Carreras, Maria C.
    Poderoso, Juan J.
    [J]. NEUROLOGY, 2010, 74 (09) : A253 - A253
  • [8] G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia
    Pchelina, Sofya N.
    Yakimovskii, Andrei F.
    Ivanova, Olga N.
    Emelianov, Anton K.
    Zakharchuk, Andrei H.
    Schwarzman, Alexander L.
    [J]. MOVEMENT DISORDERS, 2006, 21 (12) : 2234 - 2236
  • [9] The LRRK2 G2019S mutation as the cause of Parkinson’s disease in Ashkenazi Jews
    Avner Thaler
    Elissa Ash
    Ziv Gan-Or
    Avi Orr-Urtreger
    Nir Giladi
    [J]. Journal of Neural Transmission, 2009, 116 : 1473 - 1482
  • [10] A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease
    Omer, Nurit
    Giladi, Nir
    Gurevich, Tanya
    Bar-Shira, Anat
    Gana-Weisz, Mali
    Goldstein, Orly
    Kestenbaum, Meir
    Cedarbaum, Jesse M.
    Orr-Urtreger, Avi
    Mirelman, Anat
    Thaler, Avner
    [J]. MOVEMENT DISORDERS, 2020, 35 (07) : 1249 - 1253